Related Experiment Video
Updated: Dec 17, 2025

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein
Published on: January 28, 2013
Bilirubin binding affects the structure and function of alpha-2-macroglobulin.
Syed Saqib Ali1, Mohammad Khalid Zia1, Tooba Siddiqui1
1Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University , Aligarh, India.
Photo-illuminated bilirubin interacts with alpha-2-macroglobulin (α2M), causing structural changes and loss of protein activity. This binding is spontaneous and exothermic, suggesting potential immunomodulatory roles for bilirubin.
Area of Science:
- Biochemistry
- Molecular Biology
- Biophysics
Background:
- Bilirubin, an endogenous antioxidant and heme metabolite, circulates in blood bound to albumin.
- Alpha-2-macroglobulin (α2M) is a key proteinase inhibitor in vertebrate plasma.
Purpose of the Study:
- To investigate the interaction between photo-illuminated bilirubin and serum α2M.
- To elucidate the structural and functional consequences of this interaction.
Main Methods:
- Utilized biophysical and thermodynamic techniques.
- Employed ultraviolet (UV) and fluorescence spectroscopy.
- Conducted circular dichroism (CD) and Fourier-transform infrared spectroscopy (FT-IR) analyses.
Main Results:
- Bilirubin binding induced conformational changes in α2M's secondary structure.
- Observed conversion of β-sheet to α-helical structures.
- Demonstrated a subsequent loss of α2M protein activity.
- Thermodynamic analysis indicated exothermic and spontaneous binding.
Conclusions:
- Photo-illuminated bilirubin binding causes significant structural and functional modifications to α2M.
- The interaction leads to a loss of protein activity.
- Bilirubin's potential immunomodulatory properties warrant further investigation.
Related Concept Videos
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Drug Distribution: Plasma Protein Binding
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...

